Search Results for "Drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug. Results 2041 to 2050 of 2581 total matches.
ACE Inhibitors for Congestive Heart Failure
The Medical Letter on Drugs and Therapeutics • Oct 21, 1988 (Issue 777)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
The angiotensin-converting enzyme (ACE) inhibitors captopril (Capoten - Squibb) and enalapril (Vasotec - Merck) are now widely used to treat chronic congestive heart failure that has not responded adequately to digitalis and diuretics (Medical Letter, 30:13, Jan 29, 1988). Recently, some cardiologists have debated whether ACE inhibitors should also be used as first-line agents for treatment of this condition (WW Parmley et al, J Am Coll Cardiol, 12:265, July 1988).
Levamisole With Fluorouracil For Colon Cancer
The Medical Letter on Drugs and Therapeutics • Oct 06, 1989 (Issue 802)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Levamisole (Janssen), an old antiparasitic drug widely used for treatment of ascariasis in animals, is now available from the National Cancer Institute (NCI) for investigational use with fluorouracil (5-FU; Adrucil; and others) as an adjuvant for treatment of resectable colon cancer that has metastasized to regional lymph nodes (Dukes stage C).
Botulinum Toxin for Ocular Muscle Disorders
The Medical Letter on Drugs and Therapeutics • Nov 02, 1990 (Issue 830)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Botulinum toxin Type A (Oculinum - Allergan), used investigationally for many years to treat ocular muscle disorders (Medical Letter, 29:101, 1987), has now been approved by the US Food and Drug Administration for intramuscular treatment of strabismus and blepharospasm in patients more than 12 years old.
Growth-Hormone-Releasing-Factor for Growth Hormone Deficiency
The Medical Letter on Drugs and Therapeutics • Jan 01, 1999 (Issue 1043)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Sermorelin acetate, a synthetic form of human growth-hormone-releasing factor has been approved by the FDA for treatment of idiopathic growth hormone deficiency in children with growth failure.
Miglitol for Type 2 Diabetes Mellitus
The Medical Letter on Drugs and Therapeutics • May 21, 1999 (Issue 1053)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Miglitol, an oral alpha-glucosidase inhibitor similar to acarbase, is now available for treatment of type 2 diabetes.
Direct-to-consumer Advertisements For Glucophage XR
The Medical Letter on Drugs and Therapeutics • Mar 19, 2001 (Issue 1100)
The Medical Letter
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 1000 Main ...
Full-page newspaper advertisements addressed to patients with type 2 diabetes are promoting the convenience of "NEW once-a-day Glucophage XR (metformin HCl extended-release tablets),"and offering a coupon for a free 30-day supply in the month of March.
Azelaic Acid (Finacea) for Rosacea
The Medical Letter on Drugs and Therapeutics • Sep 15, 2003 (Issue 1165)
The Medical Letter
On Drugs and Therapeutics
www.medicalletter.org
Published by The Medical ...
Azelaic acid 15% gel (Finacea Berlex) is now available in the US for treatment of mild to moderate rosacea. A 20% cream formulation of the drug (Azelex Allergan; Medical Letter 1996; 38:52) has been marketed here since 1996 for treatment of acne. The effectiveness of Finacea compared to its own vehicle and to metronidazole gel is discussed. Information on the drug's mechanism of action, adverse effects, dosage and cost are also included.
Potassium Iodide for Thyroid Protection in a Nuclear Accident
The Medical Letter on Drugs and Therapeutics • Apr 04, 2011 (Issue 1361)
The Medical Letter®
On Drugs and Therapeutics
Volume 53 (Issue 1361)
April 4, 2011 ...
Even though it is unlikely that people living in the US
will be at risk of significant radiation exposure from the
nuclear accident in Japan, some readers have suggested
a review of the use of potassium iodide (KI) in
such circumstances. Potassium iodide taken orally
before or at the time of exposure can limit or prevent
uptake of radioactive iodine by the thyroid gland.
A Stool DNA Test (Cologuard) for Colorectal Cancer Screening
The Medical Letter on Drugs and Therapeutics • Oct 13, 2014 (Issue 1453)
or call customer service at: 800-211-2769
Important Copyright Message
The Medical Letter®
on Drugs ...
The FDA has approved Cologuard (Exact Sciences),
a stool DNA test, to screen average-risk adults ≥50
years old for colorectal cancer.
Secondary Prevention of Stroke
The Medical Letter on Drugs and Therapeutics • Dec 08, 2014 (Issue 1457)
The Medical Letter®
on Drugs and Therapeutics
Objective Drug Reviews Since 1959
Volume 56 (Issue ...
Recent guidelines from the American Heart Association
and American Stroke Association reviewed antithrombotic
therapy options for secondary prevention of
stroke in patients who have had a stroke or transient
ischemic attack (TIA).